Ubeaud G, Chauvet-Monges A M, Monti J P, Tillement J P, Crevat A
Laboratory of Biophysics, Faculty of Pharmacy, Marseilles, France.
J Pharm Sci. 1994 Feb;83(2):165-8. doi: 10.1002/jps.2600830210.
Beyond their classical action on calcium channels, some calcium channel blockers also exhibit a calcium anti-ionophoretic effect. We studied this effect on respiratory control and Ca2+ fluxes in a mitochondrial model to compare calcium antagonists chosen among three clinical classes: vascular, cardiac, and mixed effects. Synthetic calcium ionophore A23187 decreases respiratory control and modifies Ca2+ fluxes. We show that calcium antagonists partially restore the parameters altered by A23187. By calculating the percentage of restoration, we found that vascular drugs exhibit a strong anti-ionophoretic effect, cardiac drugs exert no significant effect, and mixed calcium antagonists exert an intermediate effect. Thus, it appears possible to link the intensity of calcium anti-ionophoretic effect with the clinical interest of a calcium antagonist.
除了对钙通道的经典作用外,一些钙通道阻滞剂还表现出钙抗离子载体效应。我们在一个线粒体模型中研究了这种效应对呼吸控制和Ca2+通量的影响,以比较从三种临床类型中选择的钙拮抗剂:血管作用型、心脏作用型和混合型。合成钙离子载体A23187会降低呼吸控制并改变Ca2+通量。我们发现钙拮抗剂能部分恢复被A23187改变的参数。通过计算恢复百分比,我们发现血管作用型药物表现出强烈的抗离子载体效应,心脏作用型药物无显著作用,混合型钙拮抗剂则发挥中等效应。因此,似乎有可能将钙抗离子载体效应的强度与钙拮抗剂的临床应用价值联系起来。